Estimating the stoichiometry of human immunodeficiency virus entry

Journal of Virology

Volumn 83, Issue 3, 2009, Pages 1523-1531

  Magnus, Carsten ^a   Rusert, Peter ^b   Bonhoeffer, Sebastian ^a   Trkola, Alexandra ^b   Regoes, Roland R ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL MODEL; PREDICTION; PRIORITY JOURNAL; STOICHIOMETRY; VIRUS ENTRY;

CELL LINE; HIV; HUMANS; MEMBRANE FUSION; MODELS, THEORETICAL; TRANSFECTION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 59749083598     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01764-08     Document Type: Article

References (21)

1. Boulay, F., R. W. Doms, R. G. Webster, and A. Helenius. 1988. Posttranslational oligomerization and cooperative acid activation of mixed influenza hemagglutinin trimers. J. Cell Biol. 106:629-639.
2. Doms, R. W., P. L. Earl, S. Chakrabarti, and B. Moss. 1990. Human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain. J. Virol. 64:3537-3540.
3. Herrera, C., P. J. Klasse, C. W. Kibler, E. Michael, J. P. Moore, and S. Beddows. 2006. Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complex. Virology 351:121-132.
4. Klasse, P. J. 2007. Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody. Virology 369:245-262.
5. Louder, M. K. K., A. Sambor, E. Chertova, T. Hunte, S. Barrett, F. Ojong, E. Sanders-Buell, S. Zolla-Pazner, F. E. E. McCutchan, J. D. D. Roser, D. Gabuzda, J. D. D. Lifson, and J. R. R. Mascola. 2005. HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity. Virology 339:226-238.
6. Marzi, A., A. Wegele, and S. Pohlmann. 2006. Modulation of virion incorporation of ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization. Virology 352:345-356.
7. Ou, W., and J. Silver. 2006. Stoichiometry of murine leukemia virus envelope protein-mediated fusion and its neutralization. J. Virol. 80:11982-11990.
8. Piatak, M., Jr., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
9. R Development Core Team. 2008. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
10. Ren, X., J. Sodroski, and X. Yang. 2005. An unrelated monoclonal antibody neutralizes human immunodeficiency virus type 1 by binding to an artificial epitope engineered in a functionally neutral region of the viral envelope glycoproteins. J. Virol. 79:5616-5624.
11. Rusert, P., M. Fischer, B. Joos, C. Leemann, H. Kuster, M. Flepp, S. Bonhoeffer, H. F. Gunthard, and A. Trkola. 2004. Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol. Virology 326:113-129.
12. Salzwedel, K., and E. A. Berger. 2000. Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41. Proc. Natl. Acad. Sci. USA 97:12794-12799.
13. Sattentau, Q. J., and J. P. Moore. 1995. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182:185-196.
14. Schønning, K., O. Lund, O. S. Lund, and J.-E. S. Hansen. 1999. Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1. J. Virol. 73:8364-8370.
15. Sougrat, R., A. Bartesaghi, J. D. Lifson, A. E. Bennett, J. W. Bess, D. J. Zabransky, and S. Subramaniam. 2007. Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry. PLoS Pathog. 3:571-581.
16. Wyatt, R., and J. Sodroski. 1998. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280:1884-1888.
17. Yang, X., S. Kurteva, S. Lee, and J. Sodroski. 2005. Stoichiometry of antibody neutralization of human immunodeficiency virus type 1. J. Virol. 79:3500-3508.
18. Yang, X., S. Kurteva, X. Ren, S. Lee, and J. Sodroski. 2005. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1. J. Virol. 79:12132-12147.
19. Yang, X., S. Kurteva, X. Ren, S. Lee, and J. Sodroski. 2006. Subunit stoichiometry of human immunodeficiency virus type 1 envelope glycoprotein trimers during virus entry into host cells. J. Virol. 80:4388-4395.
20. Yang, X., I. Lipchina, S. Cocklin, I. Chaiken, and J. Sodroski. 2006. Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralization. J. Virol. 80:11404-11408.
21. Zhu, P., J. Liu, J. Bess, Jr., E. Chertova, J. D. Lifson, H. Grise, G. A. Ofek, K. A. Taylor, and K. H. Roux. 2006. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441:847-852.